S&P affirms SPC Katren

S&P said it affirmed its BB-/B long- and short-term issuer credit ratings on Russian pharmaceutical distributor SPC Katren JSC.

The outlook is stable.

“The rating affirmation reflects our view that Katren's S&P Global Ratings-adjusted leverage will remain moderate and stable, with an adjusted debt-to-EBITDA ratio of about 2.3x in the next two years,” S&P said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.